Aaron Henry J
Brookings Institution, Washington, DC, USA.
Health Aff (Millwood). 2003 Jan-Jun;Suppl Web Exclusives:W3-28-36. doi: 10.1377/hlthaff.w3.28.
Debate about whether to restrain health care spending is intensifying. Much of the debate revolves around efficient research allocation. The possible impact of cost control on the advance of medical technology merits more attention. Public and private efforts to slow growth of health spending have not enjoyed much success. Most recently, managed care failed because administrators lacked political legitimacy. Politically established budget limits can hold down spending, but the United States seems unwilling to adopt them; even if it were, the technology to administer them rationally does not exist. In this situation, efforts to hold down cost growth carry grave risks.
关于是否抑制医疗保健支出的争论正在加剧。大部分争论都围绕着有效的研究资源分配。成本控制对医疗技术进步的可能影响值得更多关注。公共和私人部门为减缓医疗支出增长所做的努力成效不大。最近,管理式医疗失败了,因为管理人员缺乏政治合法性。政治上设定的预算限制可以抑制支出,但美国似乎不愿意采用;即便采用,合理管理这些限制的技术也不存在。在这种情况下,抑制成本增长的努力存在巨大风险。